Unity Biotechnology Inc (UBX)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
Apr 29, 16:00
1.50
-0.01
(-0.66%)
Pre-Market: 08:36
Unity Biotechnology Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2022 | 0.4948 |
March 31, 2022 | 0.3821 |
December 31, 2021 | 0.3603 |
September 30, 2021 | 0.4345 |
June 30, 2021 | 0.3776 |
March 31, 2021 | 0.3089 |
December 31, 2020 | 0.2957 |
September 30, 2020 | 0.2478 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Date | Value |
---|---|
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.4948
Maximum
Jun 2022
0.2232
Average
0.2957
Median
Dec 2020
Debt to Equity Ratio Benchmarks
PAVmed Inc | -0.8211 |
Perspective Therapeutics Inc | 0.0229 |
Electromed Inc | 0.00 |
Xtant Medical Holdings Inc | 0.4243 |
Asensus Surgical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 65.69M |
Total Liabilities (Quarterly) | 37.29M |
Shareholders Equity (Quarterly) | 28.40M |